Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study.

Date publication

juillet 2015

Journal

BMC cardiovascular disorders

Auteurs

Membres identifiés du Cancéropôle Est :
Pr VERGES Bruno

Tous les auteurs :
Vergès B, Patois-Vergès B, Iliou MC, Simoneau-Robin I, Bertrand JH, Feige JM, Douard H, Catargi B, Fischbach M,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/26152221

Résumé

Gain in VO2 peak after cardiac rehabilitation (CR) following an acute coronary syndrome (ACS), is associated with reduced mortality and morbidity. We have previously shown in CR, that gain in VO2 peak is reduced in Type 2 diabetic patients and that response to CR is impaired by hyperglycemia.

Mots clés

Acute Coronary Syndrome, complications, Aged, Blood Glucose, metabolism, Diabetes Mellitus, Type 2, complications, Exercise Therapy, methods, Female, Fructosamine, metabolism, Hemoglobin A, Glycosylated, metabolism, Humans, Hypoglycemic Agents, therapeutic use, Insulin Aspart, therapeutic use, Insulin Glargine, therapeutic use, Male, Metformin, therapeutic use, Middle Aged, Oxygen Consumption, Pulmonary Gas Exchange, Pulmonary Ventilation, Treatment Outcome

Référence

BMC Cardiovasc Disord. 2015 Jul;15:64